What is the GL Pharm Tech Corp stock price forecast?

GL Pharm Tech Corp is currently trading at ₩890. View real-time AI analysis on Alpha Lenz.

What is GL Pharm Tech Corp insider trading activity?

View the latest insider trading data for GL Pharm Tech Corp on Alpha Lenz.

What is GL Pharm Tech Corp's P/E ratio?

GL Pharm Tech Corp's P/E ratio is -28.3.

GL Pharm Tech Corp

KRX · 204840

₩890+0(+0.00%)Market closed

Ask about GL Pharm Tech Corp's future dividend policy...

Alpha Chat Insight

“GL Pharm Tech Corp trades at a P/E of -28.3 (undervalued) with modest ROE of -14.6%. 3Y revenue CAGR of 28.0% highlights clear growth momentum.”

Ask for details →

Company Overview

GL Pharm Tech Corp is a company focused on the development and manufacturing of specialty pharmaceutical products. The primary function of GL Pharm Tech Corp is to provide advanced drug delivery solutions, enhancing therapeutic outcomes while improving patient compliance. The company is known for its innovation in drug formulation technologies, specializing in oral dispersible films and other novel drug delivery systems. This allows them to cater to various therapeutic areas, including central nervous system disorders and pain management. Operating within the pharmaceutical sector, GL Pharm Tech Corp plays a crucial role in supplying enhanced medication options to healthcare providers and patients. By focusing on these niche solutions, the company contributes to advancements in the pharmaceutical industry, addressing unmet medical needs and offering competitive alternatives to traditional delivery methods.

CEO김용일, 진성필

Websitehttps://www.glpt.co.kr

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees27

Company Statistics

FY 2024

Profile

₩69,018,615,340Market Cap

₩26,047,952,250Revenue

77.55MShares Out

27Employees

Margins

39.57%Gross

1.47%EBITDA

-6.79%Operating

-8.95%Pre-Tax

-8.97%Net

Valuation

-28.28P/E

3.36P/B

2.54EV/Sales

199.39EV/EBITDA

-13.12P/FCF

Growth (CAGR)

27.98%Rev 3Yr

19.68%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-5.68%ROA

-14.63%ROE

-3.80%ROIC

Financial Health

₩4,257,704,100Cash & Cash Equivalents

₩18,514,704,340Net Debt

115.78%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“GL Pharm Tech Corp trades at a P/E of -28.3 (undervalued) with modest ROE of -14.6%. 3Y revenue CAGR of 28.0% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

GL Pharm Tech Corp (ticker: 204840) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 27 employees. Market cap is $69.0B.

The current price is ₩890 with a P/E ratio of -28.28x and P/B of 3.36x.

ROE is -14.63% and operating margin is -6.79%. Annual revenue is $26.0B.